Heart Hypertrophy During Pregnancy: A Better Functioning Heart?

Trends in Cardiovascular Medicine

Volumn 16, Issue 8, 2006, Pages 285-291

  Eghbali, Mansoureh ^a   Wang, Yibin ^a   Toro, Ligia ^a   Stefani, Enrico ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); ATRIAL NATRIURETIC FACTOR; BIOLOGICAL MARKER; CYCLIC GMP; ESTROGEN; MEMBRANE PROTEIN; MYOSIN HEAVY CHAIN; NITRIC OXIDE SYNTHASE; PHOSPHOLAMBAN; PROTEIN TYROSINE KINASE;

ENZYME ACTIVITY; HEART ARRHYTHMIA; HEART FUNCTION; HEART HYPERTROPHY; HEART PROTECTION; HEART VENTRICLE OVERLOAD; HEART VENTRICLE REMODELING; HUMAN; NONHUMAN; PREGNANCY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PUERPERIUM; QT DISPERSION; REVIEW; RISK ASSESSMENT; SIGNAL TRANSDUCTION;

ANIMALS; CARDIOMEGALY; ESTROGENS; FEMALE; HUMANS; MICE; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS; RATS; SHAL POTASSIUM CHANNELS; SIGNAL TRANSDUCTION;

EID: 33750016020     PISSN: 10501738     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tcm.2006.07.001     Document Type: Review

References (72)

1. Adams J., Sakata Y., Davis M., et al. Enhanced Galphaq signaling: a common pathway mediates cardiac hypertrophy and apoptotic heart failure. Proc Natl Acad Sci U S A 95 (1998) 10140-10145
2. An W., Bowlby M., Betty M., et al. Modulation of A-type potassium channels by a family of calcium sensors. Nature 403 (2000) 553-556
3. Aoyagi T., Fujii A., Flanagan M., et al. Maturation-dependent differences in regulation of sarcoplasmic reticulum Ca(2+) ATPase in sheep myocardium in response to pressure overload: a possible mechanism for maturation-dependent systolic and diastolic dysfunction. Pediatr Res 50 (2001) 246-253
4. Babiker F., Lips D., Meyer R., et al. Estrogen receptor beta protects the murine heart against left ventricular hypertrophy. Arterioscler Thromb Vasc Biol 26 (2006) 1524-1530
5. Booz G. Putting the brakes on cardiac hypertrophy: exploiting the NO-cGMP counter-regulatory system. Hypertension 45 (2005) 341-346
6. Cantor E., Babick A., Vasanji Z., et al. A comparative serial echocardiographic analysis of cardiac structure and function in rats subjected to pressure or volume overload. J Mol Cell Cardiol 38 (2005) 777-786
7. Capuano V., Ruchon Y., Antoine S., et al. Ventricular hypertrophy induced by mineralocorticoid treatment or aortic stenosis differentially regulates the expression of cardiac K+ channels in the rat. Mol Cell Biochem 237 (2002) 1-10
8. Carabello B. Concentric versus eccentric remodeling. J Card Fail 8 (2002) S258-S263
9. Castoria G., Migliaccio A., Bilancio A., et al. PI3-kinase in concert with Src promotes the S-phase entry of oestradiol-stimulated MCF-7 cells. EMBO J 20 (2001) 6050-6059
10. Chizzonite R., Everett A., Clark W., et al. Isolation and characterization of two molecular variants of myosin heavy chain from rabbit ventricle. Change in their content during normal growth and after treatment with thyroid hormone. J Biol Chem 257 (1982) 2056-2065
11. Daniels S., Meyer R., Liang Y., et al. Echocardiographically determined left ventricular mass index in normal children, adolescents and young adults. J Am Coll Cardiol 12 (1988) 703-708
12. DeBosch B., Treskov I., Lupu T., et al. Akt1 is required for physiological cardiac growth. Circulation 113 (2006) 2097-2104
13. De Windt L., Lim H., Bueno O., et al. Targeted inhibition of calcineurin attenuates cardiac hypertrophy in vivo. Proc Natl Acad Sci U S A 98 (2001) 3322-3327
14. Dorn G., and Force T. Protein kinase cascades in the regulation of cardiac hypertrophy. J Clin Invest 115 (2005) 527-537
15. Eghbali M., Deva R., Alioua A., et al. Molecular and functional signature of heart hypertrophy during pregnancy. Circ Res 96 (2005) 1208-1216
16. Esposito G., Prasad S., Rapacciuolo A., et al. Cardiac overexpression of a G(q) inhibitor blocks induction of extracellular signal-regulated kinase and c-Jun NH(2)-terminal kinase activity in in vivo pressure overload. Circulation 103 (2001) 1453-1458
17. Gealekman O., Abassi Z., Rubinstein I., et al. Role of myocardial inducible nitric oxide synthase in contractile dysfunction and beta-adrenergic hyporesponsiveness in rats with experimental volume-overload heart failure. Circulation 105 (2002) 236-243
18. Gowda R., Khan I., Mehta N., et al. Cardiac arrhythmias in pregnancy: clinical and therapeutic considerations. Int J Cardiol 88 (2003) 129-133
19. Guo W., Jung W., Marionneau C., et al. Targeted deletion of Kv4.2 eliminates I(to,f) and results in electrical and molecular remodeling, with no evidence of ventricular hypertrophy or myocardial dysfunction. Circ Res 97 (2005) 1342-1350
20. Hainsey T., Csiszar A., Sun S., et al. Cyclosporin A does not block exercise-induced cardiac hypertrophy. Med Sci Sports Exerc 34 (2002) 1249-1254
21. Hansson M., and Forsgren S. Expression of brain natriuretic peptide in the rat heart studies during heart growth and in relation to sympathectomy. Microsc Res Tech 64 (2004) 30-42
22. Harris I., Zhang S., Treskov I., et al. Raf-1 kinase is required for cardiac hypertrophy and cardiomyocyte survival in response to pressure overload. Circulation 110 (2004) 718-723
23. Hart G. Cellular electrophysiology in cardiac hypertrophy and failure. Cardiovasc Res 28 (1994) 933-946
24. Hart G. Exercise-induced cardiac hypertrophy: a substrate for sudden death in athletes?. Exp Physiol 88 (2003) 639-644
25. Hayakawa Y., Chandra M., Miao W., et al. Inhibition of cardiac myocyte apoptosis improves cardiac function and abolishes mortality in the peripartum cardiomyopathy of Galpha(q) transgenic mice. Circulation 108 (2003) 3036-3041
26. Iemitsu M., Maeda S., Jesmin S., et al. Activation pattern of MAPK signaling in the hearts of trained and untrained rats following a single bout of exercise. J Appl Physiol 101 (2006) 151-163
27. Iemitsu M., Maeda S., Miyauchi T., et al. Gene expression profiling of exercise-induced cardiac hypertrophy in rats. Acta Physiol Scand 185 (2005) 259-270
28. Iemitsu M., Miyauchi T., Maeda S., et al. Physiological and pathological cardiac hypertrophy induce different molecular phenotypes in the rat. Am J Physiol Regul Integr Comp Physiol 281 (2001) R2029-R2036
29. Jankowski M., Rachelska G., Donghao W., et al. Estrogen receptors activate atrial natriuretic peptide in the rat heart. Proc Natl Acad Sci U S A 98 (2001) 11765-11770
30. Jankowski M., Wang D., Mukaddam-Daher S., et al. Pregnancy alters nitric oxide synthase and natriuretic peptide systems in the rat left ventricle. J Endocrinol 184 (2005) 209-217
31. Jiang Q., Huang X., Yang G., et al. Cardiac hypertrophy induced by prostaglandin F(2alpha) may be mediated by calcineurin signal transduction pathway in rats. Sheng Li Xue Bao 57 (2005) 742-748
32. Kaab S., Dixon J., Duc J., et al. Molecular basis of transient outward potassium current downregulation in human heart failure: a decrease in Kv4.3 mRNA correlates with a reduction in current density. Circulation 98 (1998) 1383-1393
33. Kato T., Muraski J., Chen Y., et al. Atrial natriuretic peptide promotes cardiomyocyte survival by cGMP-dependent nuclear accumulation of zyxin and Akt. J Clin Invest 115 (2005) 2716-2730
34. Kim H., Laing M., and Muller W. c-Src-null mice exhibit defects in normal mammary gland development and ERalpha signaling. Oncogene 24 (2005) 5629-5636
35. Kiriazis H., Sato Y., Kadambi V., et al. Hypertrophy and functional alterations in hyperdynamic phospholamban-knockout mouse hearts under chronic aortic stenosis. Cardiovasc Res 53 (2002) 372-381
36. Kovacic B., Ilic D., Damsky C., et al. c-Src activation plays a role in endothelin-dependent hypertrophy of the cardiac myocyte. J Biol Chem 273 (1998) 35185-35193
37. Lebeche D., Kaprielian R., Del Monte F., et al. In vivo cardiac gene transfer of Kv4.3 abrogates the hypertrophic response in rats after aortic stenosis. Circulation 110 (2004) 3435-3443
38. Lee J., Nishiyama A., Kambe F., et al. Down regulation of voltage-gated K(+) channels in rat heart with right ventricular hypertrophy. Am J Physiol 277 (1999) H1725-H1731
39. Li Z., Gao Y., and Tang Z. Differential expression of cardiac immediate early and late response gene in exercise-induced and hypertensive cardiac hypertrophic remodeling. Sheng Li Xue Bao 50 (1998) 551-556
40. Liao Y., Asakura M., Takashima S., et al. Celiprolol, a vasodilatory beta-blocker, inhibits pressure overload-induced cardiac hypertrophy and prevents the transition to heart failure via nitric oxide-dependent mechanisms in mice. Circulation 110 (2004) 692-699
41. Lim H., De Windt L., Steinberg L., et al. Calcineurin expression, activation, and function in cardiac pressure-overload hypertrophy. Circulation 101 (2000) 2431-2437
42. MacCarthy P., and Shah A. Impaired endothelium-dependent regulation of ventricular relaxation in pressure-overload cardiac hypertrophy. Circulation 101 (2000) 1854-1860
43. Magga J., Marttila M., Mantymaa P., et al. Brain natriuretic peptide in plasma, atria, and ventricles of vasopressin- and phenylephrine-infused conscious rats. Endocrinology 134 (1994) 2505-2515
44. Miyamoto T., Takeishi Y., Takahashi H., et al. Activation of distinct signal transduction pathways in hypertrophied hearts by pressure and volume overload. Basic Res Cardiol 99 (2004) 328-337
45. Molkentin J. Calcineurin-NFAT signaling regulates the cardiac hypertrophic response in coordination with the MAPKs. Cardiovasc Res 63 (2004) 467-475
46. Nerbonne J., and Kass R. Molecular physiology of cardiac repolarization. Physiol Rev 85 (2005) 1205-1253
47. Panou F., Kafkas N., Michelakakis N., et al. Effect of different AV delays on left ventricular diastolic function and ANF levels in DDD paced hypertensive patients during daily activity and exercise. Pacing Clin Electrophysiol 22 (1999) 635-642
48. Patten R., Pourati I., Aronovitz M., et al. 17beta-estradiol reduces cardiomyocyte apoptosis in vivo and in vitro via activation of phospho-inositide-3 kinase/Akt signaling. Circ Res 95 (2004) 692-699
49. Petrich B., and Wang Y. Stress-activated MAP kinases in cardiac remodeling and heart failure; new insights from transgenic studies. Trends Cardiovasc Med 14 (2004) 50-55
50. Pluim B., Zwinderman A., Van der L., et al. The athlete's heart. A meta-analysis of cardiac structure and function. Circulation 101 (2000) 336-344
51. Ro A., and Frishman W. Peripartum cardiomyopathy. Cardiol Rev 14 (2006) 35-42
52. Ropero A., Eghbali M., Minosyan T., et al. Heart estrogen receptor alpha: distinct membrane and nuclear distribution patterns and regulation by estrogen. J Mol Cell Cardiol 41 (2006) 496-510
53. Schannwell C., Zimmermann T., Schneppenheim M., et al. Left ventricular hypertrophy and diastolic dysfunction in healthy pregnant women. Cardiology 97 (2002) 73-78
54. Skavdahl M., Steenbergen C., Clark J., et al. Estrogen receptor-beta mediates male-female differences in the development of pressure overload hypertrophy. Am J Physiol Heart Circ Physiol 288 (2005) H469-H476
55. 2+ signaling in severe but compensated canine left ventricular hypertrophy. Circ Res 97 (2005) 457-464
56. Sopontammarak S., Aliharoob A., Ocampo C., et al. Mitogen-activated protein kinases (p38 and c-Jun NH2-terminal kinase) are differentially regulated during cardiac volume and pressure overload hypertrophy. Cell Biochem Biophys 43 (2005) 61-76
57. Su X., Brower G., Janicki J., et al. Differential expression of natriuretic peptides and their receptors in volume overload cardiac hypertrophy in the rat. J Mol Cell Cardiol 31 (1999) 1927-1936
58. Szymanska G., Stromer H., Silverman M., et al. Altered phosphorylation of sarcoplasmic reticulum contributes to the diminished contractile response to isoproterenol in hypertrophied rat hearts. Pflugers Arch 439 (1999) 1-10
59. Takeishi Y., Huang Q., Abe J., et al. Src and multiple MAP kinase activation in cardiac hypertrophy and congestive heart failure under chronic pressure-overload: comparison with acute mechanical stretch. J Mol Cell Cardiol 33 (2001) 1637-1648
60. + channel subunit mRNAs in ventricles of renovascular hypertensive rats. Circ Res 81 (1997) 533-539
61. Tomaselli G., and Marban E. Electrophysiological remodeling in hypertrophy and heart failure. Cardiovasc Res 42 (1999) 270-283
62. Van Eickels M., Grohe C., Cleutjens J., et al. 17beta-estradiol attenuates the development of pressure-overload hypertrophy. Circulation 104 (2001) 1419-1423
63. Van Natta T., Ralphe J., Mascio C., et al. Ontogeny of vascular growth factors in perinatal sheep myocardium. J Soc Gynecol Investig 11 (2004) 503-510
64. Wang X., and Bdel-Rahman A. Estrogen modulation of eNOS activity and its association with caveolin-3 and calmodulin in rat hearts. Am J Physiol Heart Circ Physiol 282 (2002) H2309-H2315
65. Weiner C., Lizasoain I., Baylis S., et al. Induction of calcium-dependent nitric oxide synthases by sex hormones. Proc Natl Acad Sci U S A 91 (1994) 5212-5216
66. Wilkins B., Dai Y., Bueno O., et al. Calcineurin/NFAT coupling participates in pathological, but not physiological, cardiac hypertrophy. Circ Res 94 (2004) 110-118
67. Woods R. Cardioprotective functions of atrial natriuretic peptide and B-type natriuretic peptide: a brief review. Clin Exp Pharmacol Physiol 31 (2004) 791-794
68. Wu C., Liu J., Wu J., et al. 17beta-estradiol reduces cardiac hypertrophy mediated through the up-regulation of P13K/Akt and the suppression of calcineurin/NF-AT3 signaling pathways in rats. Life Sci 78 (2005) 347-356
69. Yamazaki T., and Yazaki Y. Molecular basis of cardiac hypertrophy. Z Kardiol 89 (2000) 1-6
70. 2+/calmodulin-dependent protein kinase II in cardiac hypertrophy and heart failure. Cardiovasc Res 63 (2004) 476-486
71. Zhang T., Cui B., and Dai D. Down-regulation of Kv4.2 and Kv4.3 channel gene expression in right ventricular hypertrophy induced by monocrotaline in rat. Acta Pharmacol Sin 25 (2004) 226-230
72. Zobel C., Kassiri Z., Nguyen T., et al. Prevention of hypertrophy by overexpression of Kv4.2 in cultured neonatal cardiomyocytes. Circulation 106 (2002) 2385-2391